237 related articles for article (PubMed ID: 30802001)
1. A Combination of Intrathecal and Intramuscular Application of Human Mesenchymal Stem Cells Partly Reduces the Activation of Necroptosis in the Spinal Cord of SOD1
Řehořová M; Vargová I; Forostyak S; Vacková I; Turnovcová K; Kupcová Skalníková H; Vodička P; Kubinová Š; Syková E; Jendelová P
Stem Cells Transl Med; 2019 Jun; 8(6):535-547. PubMed ID: 30802001
[TBL] [Abstract][Full Text] [Related]
2. Analysis of the therapeutic potential of different administration routes and frequencies of human mesenchymal stromal cells in the SOD1
Bursch F; Rath KJ; Sarikidi A; Böselt S; Kefalakes E; Osmanovic A; Thau-Habermann N; Klöß S; Köhl U; Petri S
J Tissue Eng Regen Med; 2019 Apr; 13(4):649-663. PubMed ID: 30811816
[TBL] [Abstract][Full Text] [Related]
3. Macrophage-mediated inflammation and glial response in the skeletal muscle of a rat model of familial amyotrophic lateral sclerosis (ALS).
Van Dyke JM; Smit-Oistad IM; Macrander C; Krakora D; Meyer MG; Suzuki M
Exp Neurol; 2016 Mar; 277():275-282. PubMed ID: 26775178
[TBL] [Abstract][Full Text] [Related]
4. Human mesenchymal stromal cells ameliorate the phenotype of SOD1-G93A ALS mice.
Zhao CP; Zhang C; Zhou SN; Xie YM; Wang YH; Huang H; Shang YC; Li WY; Zhou C; Yu MJ; Feng SW
Cytotherapy; 2007; 9(5):414-26. PubMed ID: 17786603
[TBL] [Abstract][Full Text] [Related]
5. Deletion of
Dermentzaki G; Politi KA; Lu L; Mishra V; Pérez-Torres EJ; Sosunov AA; McKhann GM; Lotti F; Shneider NA; Przedborski S
eNeuro; 2019; 6(1):. PubMed ID: 30815534
[TBL] [Abstract][Full Text] [Related]
6. Mesenchymal stromal cells prolong the lifespan in a rat model of amyotrophic lateral sclerosis.
Forostyak S; Jendelova P; Kapcalova M; Arboleda D; Sykova E
Cytotherapy; 2011 Oct; 13(9):1036-46. PubMed ID: 21736505
[TBL] [Abstract][Full Text] [Related]
7. Multiple administrations of human marrow stromal cells through cerebrospinal fluid prolong survival in a transgenic mouse model of amyotrophic lateral sclerosis.
Zhang C; Zhou C; Teng JJ; Zhao RL; Song YQ; Zhang C
Cytotherapy; 2009; 11(3):299-306. PubMed ID: 19333801
[TBL] [Abstract][Full Text] [Related]
8. Direct muscle delivery of GDNF with human mesenchymal stem cells improves motor neuron survival and function in a rat model of familial ALS.
Suzuki M; McHugh J; Tork C; Shelley B; Hayes A; Bellantuono I; Aebischer P; Svendsen CN
Mol Ther; 2008 Dec; 16(12):2002-10. PubMed ID: 18797452
[TBL] [Abstract][Full Text] [Related]
9. Pericytes Extend Survival of ALS SOD1 Mice and Induce the Expression of Antioxidant Enzymes in the Murine Model and in IPSCs Derived Neuronal Cells from an ALS Patient.
Coatti GC; Frangini M; Valadares MC; Gomes JP; Lima NO; Cavaçana N; Assoni AF; Pelatti MV; Birbrair A; de Lima ACP; Singer JM; Rocha FMM; Da Silva GL; Mantovani MS; Macedo-Souza LI; Ferrari MFR; Zatz M
Stem Cell Rev Rep; 2017 Oct; 13(5):686-698. PubMed ID: 28710685
[TBL] [Abstract][Full Text] [Related]
10. Intravenous infusion of mesenchymal stem cells delays disease progression in the SOD1G93A transgenic amyotrophic lateral sclerosis rat model.
Magota H; Sasaki M; Kataoka-Sasaki Y; Oka S; Ukai R; Kiyose R; Onodera R; Kocsis JD; Honmou O
Brain Res; 2021 Apr; 1757():147296. PubMed ID: 33516815
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of Enhanced Phrenic Long-Term Facilitation in
Nichols NL; Satriotomo I; Allen LL; Grebe AM; Mitchell GS
J Neurosci; 2017 Jun; 37(24):5834-5845. PubMed ID: 28500219
[TBL] [Abstract][Full Text] [Related]
12. Necroptosis is dispensable for motor neuron degeneration in a mouse model of ALS.
Wang T; Perera ND; Chiam MDF; Cuic B; Wanniarachchillage N; Tomas D; Samson AL; Cawthorne W; Valor EN; Murphy JM; Turner BJ
Cell Death Differ; 2020 May; 27(5):1728-1739. PubMed ID: 31745214
[TBL] [Abstract][Full Text] [Related]
13. Intravenous mesenchymal stem cells improve survival and motor function in experimental amyotrophic lateral sclerosis.
Uccelli A; Milanese M; Principato MC; Morando S; Bonifacino T; Vergani L; Giunti D; Voci A; Carminati E; Giribaldi F; Caponnetto C; Bonanno G
Mol Med; 2012 Jul; 18(1):794-804. PubMed ID: 22481270
[TBL] [Abstract][Full Text] [Related]
14. MPO/HOCl Facilitates Apoptosis and Ferroptosis in the SOD1
Peng J; Pan J; Mo J; Peng Y
Oxid Med Cell Longev; 2022; 2022():8217663. PubMed ID: 35178161
[TBL] [Abstract][Full Text] [Related]
15. An anthocyanin-enriched extract from strawberries delays disease onset and extends survival in the hSOD1
Winter AN; Ross EK; Wilkins HM; Stankiewicz TR; Wallace T; Miller K; Linseman DA
Nutr Neurosci; 2018 Jul; 21(6):414-426. PubMed ID: 28276271
[TBL] [Abstract][Full Text] [Related]
16. Human neural stem cell replacement therapy for amyotrophic lateral sclerosis by spinal transplantation.
Hefferan MP; Galik J; Kakinohana O; Sekerkova G; Santucci C; Marsala S; Navarro R; Hruska-Plochan M; Johe K; Feldman E; Cleveland DW; Marsala M
PLoS One; 2012; 7(8):e42614. PubMed ID: 22916141
[TBL] [Abstract][Full Text] [Related]
17. In-vivo effects of knocking-down metabotropic glutamate receptor 5 in the SOD1
Bonifacino T; Cattaneo L; Gallia E; Puliti A; Melone M; Provenzano F; Bossi S; Musante I; Usai C; Conti F; Bonanno G; Milanese M
Neuropharmacology; 2017 Sep; 123():433-445. PubMed ID: 28645622
[TBL] [Abstract][Full Text] [Related]
18. Chimerization of astroglial population in the lumbar spinal cord after mesenchymal stem cell transplantation prolongs survival in a rat model of amyotrophic lateral sclerosis.
Boucherie C; Schäfer S; Lavand'homme P; Maloteaux JM; Hermans E
J Neurosci Res; 2009 Jul; 87(9):2034-46. PubMed ID: 19267424
[TBL] [Abstract][Full Text] [Related]
19. Systemic administration of scAAV9-IGF1 extends survival in SOD1
Wang W; Wen D; Duan W; Yin J; Cui C; Wang Y; Li Z; Liu Y; Li C
Brain Res Bull; 2018 May; 139():203-210. PubMed ID: 29499331
[TBL] [Abstract][Full Text] [Related]
20. Isoform-selective as opposed to complete depletion of fibroblast growth factor 2 (FGF-2) has no major impact on survival and gene expression in SOD1
Kefalakes E; Sarikidi A; Bursch F; Ettcheto M; Schmuck M; Rumpel R; Grothe C; Petri S
Eur J Neurosci; 2019 Sep; 50(6):3028-3045. PubMed ID: 30883949
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
